Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pulmonary Arterial Hypertension Associated With Connective Tissue Disease clinical trials
2 of 2 indexed Pulmonary Arterial Hypertension Associated With Connective Tissue Disease trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Pulmonary Arterial Hypertension Associated With Connective Tissue Disease: 2 US clinical trials tracked, 2 recruiting.
Pulmonary Arterial Hypertension Associated With Connective Tissue Disease is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Rutgers, The State University of New Jersey, running 1 of these trials.
Enrollment posture brief
Registry condition pulmonary-arterial-hypertension-associated-with-connective-tissue-disease
OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Pulmonary Arterial Hypertension Associated With Connective Tissue Disease lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pulmonary Arterial Hypertension Associated With Connective Tissue Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pulmonary Arterial Hypertension Associated With Connective Tissue Disease is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Pulmonary Arterial Hypertension Associated With Connective Tissue Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pulmonary Arterial Hypertension Associated With Connective Tissue Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pulmonary Arterial Hypertension Associated With Connective Tissue Disease page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Pulmonary Arterial Hypertension Associated With Connective Tissue Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Rutgers, The State University of New Jersey sponsors the most Pulmonary Arterial Hypertension Associated With Connective Tissue Disease trials on record, review their full trial history before evaluating a specific study. See Rutgers, The State University of New Jersey's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pulmonary Arterial Hypertension Associated With Connective Tissue Disease condition card totals 2 registered trials; most-linked intervention Health surveys; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.